ARCHIVES

FDA News: FDA Taking Comments on “First Generic” ANDA Process

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995

NCI Advisory Group, other Cancer Meetings

July 29, 1988

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

April 15, 2005

Letters To The Editor From I-ELCAP’s Claudia Henschke and Steve Walker From Abigail Alliance.

July 8, 2011

GAO Says Multiple Year Funding Not Legal; Weicker Demands Assurance That Administration Will Comply

March 29, 1985

NCCR Calls For 15% Increase In NIH Budget, “Investment Priority”

February 11, 1994